Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 1/20 | 0.53 |
| ▸ | FDPS | P14324 | 1/20 | 0.53 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | MIF | P14174 | 1/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29899404 | 0.98 | GGPS1 (0.51) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL3796430 | 0.85 | GGPS1 (0.50) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL9797098 | 0.81 | GGPS1 (0.56) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL28036377 | 0.81 | GGPS1 (0.53) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL5755912 | 0.81 | GGPS1 (0.53) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL8360107 | 0.81 | GGPS1 (0.53) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL25767061 | 0.81 | GGPS1 (0.53) | GGPS1FDPSGPR84DRD4DRD3 | |
| SCHEMBL18265799 | 0.81 | GGPS1 (0.53) | GGPS1FDPSGPR84DRD4DRD3 | |
| Hydrochloric Acid SCHEMBL2180991 | 0.79 | GGPS1 (0.51) | GGPS1FDPSGPR84DRD4DRD3 | |
| Hydrochloric Acid SCHEMBL5655467 | 0.79 | GGPS1 (0.55) | GGPS1FDPSGPR84DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116769295-B | Conductive PC (polycarbonate) for conductive carrier tape sheet and preparation method thereof | 浦江亿通塑胶电子有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-116769295-A | Conductive PC (polycarbonate) for conductive carrier tape sheet and preparation method thereof | 浦江亿通塑胶电子有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-115369430-A | Synthetic method of 3-aminomethyl imidazo [1,2-a ] pyridine derivative | 深圳职业技术学院 | 2022-11-22 | — | — | CN | claimed |
| WO-2011073269-A1 | PIPERIDINE ARYL SULFONAMIDE DERIVATIVES AS KV1.3 MODULATORS | EVOTEC AG (DE) | 2011-06-23 | — | — | WO | claimed |
| US-7342025-B2 | Substituted C-imidazo[1,2-a]pyridin-3-yl-methylamines | GRUENENTHAL GMBH (DE) | 2008-03-11 | — | — | US | claimed |
| EP-1549647-B1 | SUBSTITUTED C-IMIDAZO¬1,2-A|PYRIDIN-3-YL-METHYLAMINES | GRUENENTHAL GMBH (DE) | 2006-04-12 | — | — | EP | claimed |
| EP-1549650-B1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | GRUENENTHAL GMBH (DE) | 2006-03-22 | — | — | EP | claimed |
| US-20050239822-A1 | Substituted C-imiadazol[1,2-a] pyridin-3-yl-methylamines | GRUENENTHAL GMBH (DE) | 2005-10-27 | — | — | US | claimed |
| EP-1549650-A1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | Grünenthal GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| EP-1549647-A1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | Grünenthal GmbH (DE) | 2005-07-06 | — | — | EP | claimed |
| WO-2004035578-A1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | Grünenthal GmbH (DE) | 2004-04-29 | — | — | WO | claimed |
| WO-2004033453-A1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | Grünenthal GmbH (DE) | 2004-04-22 | — | — | WO | claimed |
| US-12358910-B2 | Heteroaromatic compounds as Vanin inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-07-15 | — | — | US | disclosed |
| CN-113166117-B | Heteroaromatic compounds as VANIN inhibitors | 勃林格殷格翰国际公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-3487856-B1 | SUBSTITUTED DIAZAHETERO-BICYCLIC COMPOUNDS AND THEIR USE | BAYER AG (DE) | 2025-01-22 | — | — | EP | disclosed |
| CN-116769295-B | Conductive PC (polycarbonate) for conductive carrier tape sheet and preparation method thereof | 浦江亿通塑胶电子有限公司 | 2024-02-23 | — | — | CN | disclosed |
| WO-2004033453-A1 | SUBSTITUTED C-IMIDAZO[1,2-A]PYRIDIN-3-YL-METHYLAMINES | Grünenthal GmbH (DE) | 2004-04-22 | — | — | WO | disclosed |
| WO-2002066478-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | ASTRAZENECA AB (SE) | 2002-08-29 | — | — | WO | disclosed |
| US-5441945-A | Bone resorption inhibitor, anticaries agent, polyvalent metal ion complex salt forming agent | HOECHST JAPAN LIMITED (JP) | 1995-08-15 | — | — | US | disclosed |
| EP-0620227-A1 | Heterocyclic iminobismethylenebisphosphonic acid derivatives | HOECHST JAPAN LIMITED (JP) | 1994-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239822-A1 | Substituted C-imiadazol[1,2-a] pyridin-3-yl-methylamines | NOS2, NOS1, NOS3 | GGPS1 899/4885FDPS 407/4885GPR84 3808/4885 |
| US-12358910-B2 | Heteroaromatic compounds as Vanin inhibitors | VHL, FANCI, PAH | GGPS1 935/4885FDPS 124/4885GPR84 2609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.